REVA bags $42m from Medtronic et al:
This article was originally published in Clinica
Executive Summary
San Diego, California-based REVA Medical has secured $42m to fund the development of its bioresorbable stents for the treatment of arterial disease. The funds were raised in a private financing round led by Cerberus Capital Management and Brookside Capital, and contributed to by new shareholders Medtronic and Pequot Management, along with existing investors Domain Partners and Group Outcome. REVA will use the proceeds to take its stents to clinical trials.